Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Neuroimmunol ; 232(1-2): 166-70, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21093932

ABSTRACT

Onconeural antibodies are found in many patients with paraneoplastic neurological syndromes (PNS) and define the disease as paraneoplastic. The study describes the presence of onconeural antibodies and PNS in 555 patients with neurological symptoms and confirmed cancer within five years, and compares the diagnostic accuracy of different antibody assays (immunoprecipitation, immunofluorescence and immunoblot). Onconeural antibodies were found in 11.9% of the patients by immunoprecipitation, in 7.0% by immunofluorescence and in 6.3% by immunoblot. PNS were present in 81.8% of the cancer patients that were seropositive by immunoprecipitation. Immunofluorescence and immunoblot failed to detect onconeural antibodies in almost one third of the PNS cases.


Subject(s)
Antibodies, Neoplasm/blood , Paraneoplastic Syndromes/diagnosis , Adult , Aged , Aged, 80 and over , Antibodies, Neoplasm/immunology , Female , Fluorescent Antibody Technique , Humans , Immunoblotting , Immunoprecipitation , Male , Middle Aged , Paraneoplastic Syndromes/blood , Paraneoplastic Syndromes/immunology , Sensitivity and Specificity , Young Adult
2.
Cancer Immunol Immunother ; 58(11): 1795-800, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19294382

ABSTRACT

PURPOSE: We assessed the frequency and levels of onconeural antibodies in 974 patients with various types of tumours, but without apparent paraneoplastic neurological syndromes (PNS). PATIENTS AND METHODS: We included patients with the following tumours: 200 small-cell lung cancer (SCLC) patients, 253 breast cancer patients, 182 ovarian cancer patients, 266 uterine cancer patients and 73 thymoma patients, as well as 52 patients with PNS and cancer and 300 healthy blood donors. Sera were screened for amphiphysin, CRMP5, Hu, Ma2, Ri and Yo antibodies using a multi-well immunoprecipitation technique. RESULTS: The most frequently detected antibodies were Hu followed by CRMP5. Ma2, Yo, amphiphysin and Ri antibodies were less common, but each was found at similar frequencies. Onconeural antibodies were present at similar levels in sera from the PNS control group and from cancer patients. Hu antibodies were rare in cancers other than SCLC. CRMP5 was the only antibody found in patients with thymoma and this antibody was more common among patients with thymoma than in other tumour patients. With one exception, coexisting antibodies were only found in patients with SCLC. The presence of onconeural antibodies in SCLC patients was not associated with prolonged survival. CONCLUSION: Onconeural antibodies are associated with various types of tumours suggesting that all antibodies should be included in the serological screening for possible PNS. The levels of onconeural antibody are not sufficiently sensitive to discriminate between cancer patients with PNS and those without.


Subject(s)
Antibodies, Neoplasm/blood , Neoplasms/immunology , Nerve Tissue Proteins/blood , Blood Donors , ELAV Proteins/immunology , Humans , Hydrolases , Microtubule-Associated Proteins , Neoplasms/mortality
SELECTION OF CITATIONS
SEARCH DETAIL
...